Related Experiment Videos
[Morbidity and mortality in systemic lupus erythematosus]
1Department of Medicine B, Center for Autoimmune diseases, Chaim Sheba Medical Center, Tel-Hashomer.
Harefuah
|January 16, 2002
Summary
Systemic lupus erythematosus (SLE) is a complex autoimmune disease impacting multiple organs. Prognosis depends on disease activity, accumulated damage, and patient quality of life.
Area of Science:
- Autoimmune diseases
- Rheumatology
- Immunology
Context:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with diverse clinical manifestations affecting multiple organ systems.
- SLE disproportionately affects females and is linked to specific immune response genes, though its etiology remains unknown.
- Recent advancements have improved understanding and treatment, enhancing patient survival and quality of life.
Purpose:
- To elucidate the key factors influencing the prognosis of Systemic Lupus Erythematosus.
- To highlight the multifaceted nature of SLE, encompassing disease activity, cumulative organ damage, and patient-reported outcomes.
Summary:
- Prognosis in SLE is determined by a triad of factors: current disease activity, the extent of irreversible organ damage accrued over time, and the patient's overall health status and quality of life.
- Effective management requires a comprehensive approach addressing inflammatory activity, preventing and managing long-term complications, and prioritizing patient well-being.
Impact:
- Improved understanding of SLE prognosis allows for more personalized treatment strategies and better patient management.
- This framework aids clinicians in predicting disease course and optimizing interventions to enhance long-term outcomes for individuals with SLE.